These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1622630)

  • 1. Flow cytometric DNA index and S-phase fraction in breast cancer in relation to other prognostic variables and to clinical outcome.
    Fernö M; Baldetorp B; Borg A; Olsson H; Sigurdsson H; Killander D
    Acta Oncol; 1992; 31(2):157-65. PubMed ID: 1622630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival.
    Coulson PB; Thornthwaite JT; Woolley TW; Sugarbaker EV; Seckinger D
    Cancer Res; 1984 Sep; 44(9):4187-96. PubMed ID: 6744328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S-phase fraction and nuclear size in long term prognosis of patients with breast cancer.
    Meyer JS; Province MA
    Cancer; 1994 Oct; 74(8):2287-99. PubMed ID: 7922981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric DNA ploidy defines patients with poor prognosis in node-negative breast cancer.
    Balslev I; Christensen IJ; Rasmussen BB; Larsen JK; Lykkesfeldt AE; Thorpe SM; Rose C; Briand P; Mouridsen HT
    Int J Cancer; 1994 Jan; 56(1):16-25. PubMed ID: 8262673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of flow cytometry to clinical factors, hormone receptors, and histopathological grade in stage I and II invasive breast carcinoma.
    Haghbin M; McCue PA; Mansfield CM; Komarnicky LT; Benammar A; Schwartz GF
    Am J Clin Oncol; 1996 Feb; 19(1):54-8. PubMed ID: 8554037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA flow cytometric analysis and prognosis of axillary lymph node-negative breast carcinoma.
    Bosari S; Lee AK; Tahan SR; Figoni MA; Wiley BD; Heatley GJ; Silverman ML
    Cancer; 1992 Oct; 70(7):1943-50. PubMed ID: 1525770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients.
    Pinto AE; André S; Soares J
    J Clin Pathol; 1999 Aug; 52(8):604-11. PubMed ID: 10645231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of age on the DNA ploidy levels of breast tumours.
    Taylor IW; Musgrove EA; Friedlander ML; Foo MS; Hedley DW
    Eur J Cancer Clin Oncol; 1983 May; 19(5):623-8. PubMed ID: 6683634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of flow cytometric DNA analysis and estrogen receptor content in breast carcinomas--a 10 year survival study.
    Ewers SB; Attewell R; Baldetorp B; Borg A; Fernö M; Långström E; Killander D
    Breast Cancer Res Treat; 1992; 24(2):115-26. PubMed ID: 8443399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S-phase fraction after gating on epithelial cells predicts recurrence in node-negative breast cancer.
    Wingren S; Stål O; Sullivan S; Brisfors A; Nordenskjöld B
    Int J Cancer; 1994 Oct; 59(1):7-10. PubMed ID: 7523314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interrelations between cellular DNA content, S-phase fraction, hormone receptor status and age in primary breast cancer. A series of 1,342 consecutively detected tumors. South-East Sweden Breast Cancer Group.
    Stål O; Brisfors A; Carstensen J; Ferraud L; Hatschek T; Nordenskjöld B
    Acta Oncol; 1992; 31(3):283-92. PubMed ID: 1622647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of S-phase fraction and hormone receptor content in the management of young breast cancer patients.
    Stål O; Carstensen J; Hatschek T; Nordenskjöld B
    Br J Cancer; 1992 Oct; 66(4):706-11. PubMed ID: 1419611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens.
    Dressler LG; Seamer LC; Owens MA; Clark GM; McGuire WL
    Cancer; 1988 Feb; 61(3):420-7. PubMed ID: 3338012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiated DNA analysis in relation to steroid receptor status, grading, and staging in human breast cancer.
    Meckenstock G; Bojar H; Hort W
    Anticancer Res; 1987; 7(4B):749-54. PubMed ID: 3674762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of DNA flow cytometry in the locally recurrent, conservatively treated breast cancer patient.
    Haffty BG; Toth M; Flynn S; Fischer D; Carter D
    J Clin Oncol; 1992 Dec; 10(12):1839-47. PubMed ID: 1453198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA ploidy and percent S-phase as prognostic factors in node-positive breast cancer: results from patients enrolled in two prospective randomized trials.
    Witzig TE; Ingle JN; Schaid DJ; Wold LE; Barlow JF; Gonchoroff NJ; Gerstner JB; Krook JE; Grant CS; Katzmann JA
    J Clin Oncol; 1993 Feb; 11(2):351-9. PubMed ID: 8426213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Independent prognostic value of hormone receptor expression and S-phase fraction in advanced breast cancer.
    Pinto AE; Mendonça E; André S; Nóbrega SD; Soares J
    Anal Quant Cytol Histol; 2002 Dec; 24(6):345-54. PubMed ID: 12508694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Flow cytophotometry parameters, hormone receptors and axillary lymph node status as prognostic factors in primary breast cancer].
    Kaufmann M; Feichter GE; Nhila A; Klinga K; Abel U
    Geburtshilfe Frauenheilkd; 1988 Oct; 48(10):705-9. PubMed ID: 3234702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA ploidy and S-phase fraction by image and flow cytometry in breast cancer fine-needle cytopunctures.
    Spyratos F; Briffod M
    Mod Pathol; 1997 Jun; 10(6):556-63. PubMed ID: 9195572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoploidy defines patients with poor prognosis in breast cancer.
    Chavez-Uribe E; Cameselle-Teijeiro J; Viñuela JE; Castro-Piñeiro C; Gude F; Forteza J; Puente-Domínguez JL
    Oncol Rep; 2007 May; 17(5):1109-14. PubMed ID: 17390052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.